Correlation Between Procter Gamble and Genscript Biotech

Can any of the company-specific risk be diversified away by investing in both Procter Gamble and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procter Gamble and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Procter Gamble and Genscript Biotech, you can compare the effects of market volatilities on Procter Gamble and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and Genscript Biotech.

Diversification Opportunities for Procter Gamble and Genscript Biotech

-0.38

Correlation Coefficient

Procter Gamble  Genscript Biotech

Very good diversification

The 3 months correlation between Procter and Genscript is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of Procter Gamble i.e., Procter Gamble and Genscript Biotech go up and down completely randomly.

Pair Corralation between Procter Gamble and Genscript Biotech

Allowing for the 90-day total investment horizon Procter Gamble is expected to under-perform the Genscript Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Procter Gamble is 6.08 times less risky than Genscript Biotech. The stock trades about -0.06 of its potential returns per unit of risk. The Genscript Biotech is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  130.00  in Genscript Biotech on May 2, 2025 and sell it today you would earn a total of  70.00  from holding Genscript Biotech or generate 53.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.88%
Values	Daily Returns

Procter Gamble  vs.  Genscript Biotech

Procter Gamble

Risk-Adjusted Performance

Very Weak

Over the last 90 days Procter Gamble has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Procter Gamble is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Genscript Biotech

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genscript Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Genscript Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Procter Gamble and Genscript Biotech

The main advantage of trading using opposite Procter Gamble and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.

The idea behind Procter Gamble and Genscript Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.